Immunological reactivity in patients with chronic diffuse liver diseases
Journal Title: Гастроентерологія - Year 2018, Vol 52, Issue 4
Abstract
Background. The aim of the study was to assess the state of the main indicators of cellular immunity and the level of cytokines in patients with chronic diffuse liver diseases (CDLD). Materials and methods. Sixty eight patients with CDLD were examined, they were divided into 4 groups depending on the etiological factors of the formation and progression of steatosis and liver fibrosis: group I — 36 patients with non-alcoholic fatty liver disease; group II — 13 persons with chronic viral hepatitis C, group III — 14 patients with alcoholic liver disease, IV group — 5 individuals with toxic hepatitis. We studied the main indicators of cellular immunity and the level of interleukin (IL) 6, IL-10 and tumor necrosis factor (TNF) α. Results. In 83.3 % of patients in group I, 76.9 % — in group II and in a half of patients in group III, there was a significant decrease in the T helper cell subpopulation. Cellular immunodeficiency in patients with CDLD leads to the formation of steatosis. In 69.2 % of patients in group II, immunoregulatory disorders indicate the persistence of hepatitis C virus and, as a consequence, the development of fibrosis. According to the results obtained, the concentration of TNF-α in patients of groups I, II and IV significantly exceeds the control values — by 6.9, 7.9 and 11.0 times, respectively (p < 0.05). The level of IL-6 is significantly higher (by 3.9 times; p < 0.05) in patients of group I compared with group IV. This indicates the progression of the immunopathological process and is a pathogenetic sign of the inadequacy of the immune system functioning in CDLD. Conclusions. The study shows that the progression of liver steatosis is accompanied by a decrease in cellular immune system and an increase in proinflammatory cytokine levels
Authors and Affiliations
O. M. Tatarchuk, V. I. Didenko, S. L. Melanich, V. Ye. Kudryavtseva
Keywords
Related Articles
- EP ID EP440813
- DOI 10.22141/2308-2097.52.4.2018.154142
- Views 93
- Downloads 0
Management of Patients with Gastroesophageal Reflux Disease in the Light of the Recent American Consensus
The paper gives a review of a new consensus on the diagnosis and management of patients with gastroesophageal reflux disease (GERD), developed by the American College of Gastroenterology, discusses how the approaches rec...
Clinical and Endoscopic Aspects of Mucousal Candidosis of the Upper Gastrointestinal Tract in Patients with Gastroenterological Diseases
The article resolves of actual problem of interrelation of clinical and endoscopic aspects of mucosal candidosis in upper part of digestive tract. The results of investigation performed in 122 patients led to reveal the...
Results of the observational cross-over PRELID 2 study (2015–2016). Part 1. The prevalence of non-alcoholic fatty liver disease, the characteristics of concomitant pathology, metabolic syndrome and its individual criteria in patients seeking general practitioners’ and gastroenterologists’ help in Ukraine
Background. In Ukraine, large-scale epidemiological studies of non-alcoholic fatty liver disease (NAFLD) were not conducted. There are no statistics on the prevalence of NAFLD in Ukraine. Different information is receive...
Clinical and Pathogenetic Features of Nonalcoholic Fatty Liver Disease in Patients with Bronchial Asthma and Obesity
Due to comorbidity of bronchial asthma (BA) and obesity, there occurs the formation of nonalcoholic fatty liver disease (NAFLD), in which changes of pathogenic links of the disease are observed. Objective of the study: t...
Features of Treatment of Patients Infected with Hepatitis C Virus Genotypes 1 And 4 by Direct-Acting Antiviral Drugs
Hepatitis C is an urgent problem today because of the low efficiency and a significant number of side effects of conventional therapy. The problem of the treatment of hepatitis C virus (HCV) genotypes 1 and 4 is particul...